Journal articles highlighted in this tipsheet are available in their entirety by calling APAfastFAX at 888-357-7924, and selecting the appropriate document number (listed below).

In the January issue of the American Journal of Psychiatry:

Patients say research gives hope

Research involving individuals with schizophrenia has become highly controversial, yet little is known about how those with mental illness view research participation. A new study from the Department of Psychiatry at the University of New Mexico, directly asked patients with schizophrenia how they felt about ethically important aspects of research with mentally ill patients; half the respondents had themselves been research subjects. The patients strongly supported such research, and many cited a sense of hope for patients as an important motivation.
[“Perspectives of Patients With Schizophrenia and Psychiatrits Regarding Ethically Important Aspects of Research Participation,” by Laura Weiss Roberts, M.D., et. al. p., 67] APAfastFAX#6941

Acetylcholinesterase inhibitors with psychotropic properties may help with Alzheimer’s

A new study released by the UCLA School of Medicine finds that acetylcholinesterase inhibitors may help control neuropsychiatric and behavioral disturbances in Alzheimer’s. These agents also may help psychiatrists and other physicians treat other disorders with cholinergic system abnormalities and neuropsychiatric symptoms.
[“Cholinesterase Inhibitors: A New Class of Psychotropic Compounds,” by Jeffrey L. Cummings, M.D., p. 4] APAfastFAX#6940

Study investigates relationship between brain signals and functions in healthy individuals

The results of a study by the State University of New York at Stony Brook and the University of Pennsylvania School of Medicine provide the first link between age-related declines in brain dopamine activity and frontal and cingulat
'"/>

Contact: Richard Ottinger
Ottinger@psych.org
202-682-6119
American Psychiatric Association
2-Jan-2000